A detailed history of Two Sigma Investments, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,062,860 shares of TGTX stock, worth $32 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,062,860
Previous 1,361,128 21.91%
Holding current value
$32 Million
Previous $24.2 Million 2.67%
% of portfolio
0.06%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.21 - $25.28 $5.13 Million - $7.54 Million
-298,268 Reduced 21.91%
1,062,860 $24.9 Million
Q2 2024

Aug 14, 2024

BUY
$13.32 - $19.19 $14.6 Million - $21.1 Million
1,097,250 Added 415.82%
1,361,128 $24.2 Million
Q1 2024

May 15, 2024

BUY
$13.02 - $21.3 $1.42 Million - $2.32 Million
109,078 Added 70.46%
263,878 $4.01 Million
Q4 2023

Feb 14, 2024

SELL
$6.68 - $18.81 $14.6 Million - $41.1 Million
-2,186,554 Reduced 93.39%
154,800 $2.64 Million
Q3 2023

Nov 14, 2023

BUY
$8.36 - $26.5 $4.26 Million - $13.5 Million
508,972 Added 27.78%
2,341,354 $19.6 Million
Q2 2023

Aug 14, 2023

BUY
$15.48 - $35.0 $7.42 Million - $16.8 Million
479,467 Added 35.44%
1,832,382 $45.5 Million
Q1 2023

May 15, 2023

BUY
$10.23 - $19.34 $3.48 Million - $6.57 Million
339,917 Added 33.56%
1,352,915 $20.3 Million
Q4 2022

Feb 14, 2023

SELL
$5.01 - $11.83 $769,355 - $1.82 Million
-153,564 Reduced 13.16%
1,012,998 $12 Million
Q3 2022

Nov 14, 2022

SELL
$4.57 - $8.4 $1.29 Million - $2.37 Million
-281,768 Reduced 19.45%
1,166,562 $6.91 Million
Q2 2022

Aug 15, 2022

BUY
$3.74 - $10.66 $2.33 Million - $6.64 Million
622,559 Added 75.39%
1,448,330 $6.16 Million
Q1 2022

May 16, 2022

BUY
$7.81 - $20.45 $6.45 Million - $16.9 Million
825,771 New
825,771 $7.85 Million
Q2 2021

Aug 16, 2021

SELL
$32.5 - $48.96 $3.85 Million - $5.8 Million
-118,438 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$41.61 - $54.3 $4.76 Million - $6.22 Million
-114,477 Reduced 49.15%
118,438 $5.71 Million
Q4 2020

Feb 16, 2021

BUY
$25.27 - $54.9 $5.89 Million - $12.8 Million
232,915 New
232,915 $12.1 Million
Q3 2020

Nov 16, 2020

SELL
$18.49 - $27.24 $4.22 Million - $6.22 Million
-228,191 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.9 - $21.84 $2.03 Million - $4.98 Million
228,191 New
228,191 $4.45 Million
Q1 2020

May 15, 2020

SELL
$7.14 - $15.99 $289,812 - $649,034
-40,590 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.1 - $11.2 $74,868 - $164,416
14,680 Added 56.66%
40,590 $451,000
Q3 2019

Nov 14, 2019

BUY
$5.38 - $8.99 $139,395 - $232,930
25,910 New
25,910 $145,000
Q1 2019

May 15, 2019

SELL
$4.02 - $8.04 $3.09 Million - $6.18 Million
-769,011 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$3.44 - $5.76 $2 Million - $3.36 Million
582,771 Added 312.91%
769,011 $3.15 Million
Q3 2018

Nov 14, 2018

BUY
$5.15 - $14.0 $959,136 - $2.61 Million
186,240 New
186,240 $1.04 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.37B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.